Alberta Investment Management Corp (AIMCo)’s Aegerion Pharmaceuticals AEGR Stock Holding History

Alberta Investment Management Corp (AIMCo)’s Portfolio AEGR Stock Details AEGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-395,868	Closed	-$10.4M	–	550
2015 Q1	$10.4M	Sell	395,868 -133,330	-25%	-$3.39M	0.11%	258
2014 Q4	$11.1M	Sell	529,198 -138,120	-21%	-$3.48M	0.12%	237
2014 Q3	$22.3M	Buy	667,318 +101,518	+18%	+$3.15M	0.23%	104
2014 Q2	$18.2M	Buy	565,800 +189,290	+50%	+$7.05M	0.2%	146
2014 Q1	$17.4M	Buy	+376,510	New	+$22.1M	0.21%	145

Other funds holding AEGR

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

NTC

North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Alberta Investment Management Corp (AIMCo)'s AEGR Position: Q2 2015 in Review

Alberta Investment Management Corp (AIMCo) sold out of Aegerion Pharmaceuticals (AEGR) in Q2 2015, closing a stake of 395,868 shares — an estimated $10.4M sold.

Alberta Investment Management Corp (AIMCo) first reported a position in AEGR in Q1 2014 and held it in 5 quarters. The position peaked at $22.3M in Q3 2014. 97 funds tracked by Wall St. Rank hold AEGR as of Q2 2015.

Alberta Investment Management Corp (AIMCo) reported no remaining Aegerion Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
Alberta Investment Management Corp (AIMCo) sold 395,868 Aegerion Pharmaceuticals shares in Q2 2015, an estimated $10.4M.
Alberta Investment Management Corp (AIMCo) first reported a position in Aegerion Pharmaceuticals in Q1 2014 and held it in 5 quarters.
Alberta Investment Management Corp (AIMCo)'s Aegerion Pharmaceuticals position peaked at $22.3M in Q3 2014.
97 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q2 2015.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q2 2015, filed 14 Aug 2015.